In Paderno Dugnano, Recipharm runs a multi-purpose plant which can manufacture several API products at a time, handling high pressure, high temperature (up to 150 degrees Celsius) and low temperature (down to –80 degrees Celsius) reactions. Different batch sizes are available ranging from 20L to 6000L, supporting early development and commercial needs. General APIs and some hormones are manufactured.
For exploratory work, optimisation and up-scaling of early syntheses, Recipharm’s development facility in Uppsala has an excellent track record in medicinal chemistry.
Recipharm also runs a dedicated beta-lactam plant for the lyophilisation of bulk API in Lainate, Italy.
Available APIs from the Paderno Dugnano facility
|Blonanserin||EU-DMF / J-DMF|
|Clenbuterol HCl||EU-DMF / CoS|
|Dex-Medetomidine HCl**||EU-DMF / US-DMF|
|Erdosteine||EU-DMF / K-DMF|
|Glimepiride||EU-DMF / CoS|
|Indapamide||EU-DMF / CoS|
|Midodrine HCl||EU-DMF / US-DMF / J-DMF|
|Prednicarbate||EU-DMF – CoS|
|Procaterol HCl Hemihydrate||EU-DMF / J-DMF|
|Ropivacaine HCl Monohydrate**||EU-DMF / CoS|
|Tenoxicam*||EU-DMF / CoS / J-DMF|
|Tulobuterol||EU-DMF / US-DMF / J-DMF|
* Oral & injectable grades
** Injectable grade
Products are not offered in countries where valid patents exist. The final responsibility with respect to third party patent rights in a specific country lies exclusively with the user.
Products under development are supplied for R&D purposes only and in compliance with Italian law and as permitted under 35 USC 271.